SBWire

Faron Pharmaceuticals Oy - Product Pipeline Review - 2014

Global Markets Direct's, 'Amplyx Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Amplyx Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

Radius Health, Inc. - Product Pipeline Review - 2014

GlobalData's clinical trial report, "Coronary Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Coronary Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'CalAsia Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the CalAsia Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Dyslipidemia - Pipeline Review, H2 2014', provides an overview of the Dyslipidemia's therapeutic pipeline.

A peptic ulcer is an open lesion that develops on the mucosal lining of the stomach and small intestine because of the caustic effect of the gastric acids and enzymes in these organs. The symptoms of peptic ulcers are pain in the abdomen, nausea, vomiting, and bloated stomach. The major symptoms include bleeding from the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. Peptic ulcers are caused mainly by a Helicobacter pylori infection followed by the overuse of OTC NSAIDs such as Naproxen, Aspirin and Ibuprofen. Peptic ulcers can be of two types based on the site of the ulcer: gastric ulcer and duodenal ulcer.

Global Markets Direct's, 'Osteoarthritis Pain - Pipeline Review, H2 2014', provides an overview of the Osteoarthritis Pain's therapeutic pipeline.

NeuroHealing Pharmaceuticals Inc. - Product Pipeline Review - 2014

ALSP, Inc. - Product Pipeline Review - 2014

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) is developing a new drug intended to treat various forms of cancer, including a recurrent form of Brian Cancer, glioblastoma multiforme. The DelMar treatment VAL-083 is in Phase l/ll trials and showing promising results.

Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014

Global Markets Direct's, 'Cognosci, Inc. - Product Pipeline Review - 2014', provides an overview of the Cognosci, Inc.'s pharmaceutical research and development focus.

Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014

Fatty Liver Disease Global Clinical Trials Review, H2, 2014

Atrial Septal Defect Global Clinical Trials Review, H2, 2014

Systemic Lupus Erythematosus - Pipeline Review, H2 2014

Haemostatix Ltd - Product Pipeline Review - 2014

Global Markets Direct's, 'Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014', provides an overview of the Diffuse Large B-Cell Lymphoma's therapeutic pipeline.

Global Markets Direct's, 'Helicobacter Pylori Infections - Pipeline Review, H2 2014', provides an overview of the Helicobacter Pylori Infections's therapeutic pipeline.

Global Markets Direct's, 'Liver Failure - Pipeline Review, H2 2014', provides an overview of the Liver Failure's therapeutic pipeline.

Global Markets Direct's, 'Echo Pharmaceuticals B.V. - Product Pipeline Review - 2014', provides an overview of the Echo Pharmaceuticals B.V.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Refractory Multiple Myeloma - Pipeline Review, H2 2014', provides an overview of the Refractory Multiple Myeloma's therapeutic pipeline.

Global Markets Direct's, 'Primary Dysmenorrhea - Pipeline Review, H2 2014', provides an overview of the Primary Dysmenorrhea's therapeutic pipeline.

Global Markets Direct's, 'Targazyme, Inc. - Product Pipeline Review - 2014', provides an overview of the Targazyme, Inc.'s pharmaceutical research and development focus.